Hanauer Stephen B, Wald Arnold
Arnold Wald, MD Section of Gastroenterology and Hepatology, University of Wisconsin School of Medicine and Public Health, 600 Highland Avenue, H6/516 CSC, Madison, WI 53792-5124, USA.
Curr Treat Options Gastroenterol. 2007 Jun;10(3):237-47. doi: 10.1007/s11938-007-0017-z.
Megacolon, defined as dilation of the abdominal colon, may occur acutely or in a chronic form. Acute megacolon that occurs in association with severe inflammation of the colon is known as toxic megacolon, whereas acute megacolon without obvious colonic disease is known as Ogilvie's syndrome. The pathophysiology and management of toxic megacolon, Ogilvie's syndrome, and chronic megacolon in adults differ significantly, and it is critically important to distinguish among these entities. Toxic megacolon is a medical emergency that requires coordinated intensive medical and surgical management. In addition to vigorous resuscitation with fluids, electrolytes, and blood products, medical treatment consists of parenteral corticosteroids, broad-spectrum antibiotics, and close monitoring of the patient. Surgical intervention is required if there is no improvement, or deterioration after 12 to 24 hours of intensive medical management, or if there is evidence of colon perforation. Ogilvie's syndrome usually occurs in hospitalized patients with serious underlying medical or surgical illnesses. Management is directed at preventing ischemia and perforation of the distended colon. Supportive therapy includes nasogastric suction, correction of fluid and electrolyte imbalances, stopping potentially aggravating medications, and decompressing the colon with a rectal tube and positional changes. Intravenous neostigmine is the only pharmacologic agent of proven efficacy; colonoscopic decompression is an alternative in patients who do not respond to neostigmine or who have conditions that contraindicate its use. Daily oral administration of polyethylene glycol electrolyte solutions appears to decrease the relapse rate after initial decompression is achieved. Chronic megacolon in adults represents advanced colon failure that does not respond to pharmacologic stimulation. Goals of therapy are to cleanse the colon, prevent impaction, and minimize stool volume and gas buildup. For patients with disabling symptoms, surgical exclusion of the colon, decompression and antegrade enemas via cecostomy, or subtotal or segmental resection may be palliative.
巨结肠定义为腹部结肠扩张,可急性或慢性发生。与结肠严重炎症相关的急性巨结肠称为中毒性巨结肠,而无明显结肠疾病的急性巨结肠称为奥吉尔维综合征。成人中毒性巨结肠、奥吉尔维综合征和慢性巨结肠的病理生理学和管理有显著差异,区分这些实体至关重要。中毒性巨结肠是一种医疗急症,需要协调的强化医疗和手术管理。除了用液体、电解质和血液制品进行积极复苏外,药物治疗包括肠外皮质类固醇、广谱抗生素以及对患者的密切监测。如果在强化医疗管理12至24小时后没有改善或病情恶化,或者有结肠穿孔的证据,则需要手术干预。奥吉尔维综合征通常发生在患有严重基础医疗或外科疾病的住院患者中。管理旨在预防扩张结肠的缺血和穿孔。支持性治疗包括鼻胃管抽吸、纠正液体和电解质失衡、停用可能加重病情的药物,以及用直肠管和体位改变使结肠减压。静脉注射新斯的明是唯一经证实有效的药物;结肠镜减压是对新斯的明无反应或有使用禁忌证的患者的一种替代方法。在首次减压后,每日口服聚乙二醇电解质溶液似乎可降低复发率。成人慢性巨结肠代表结肠晚期衰竭,对药物刺激无反应。治疗目标是清洁结肠、预防粪块嵌塞,并尽量减少粪便体积和气体积聚。对于有致残症状的患者,结肠切除、通过盲肠造口进行减压和顺行灌肠,或次全或节段性切除可能具有姑息作用。